CARDIOPROGRESS
Foundation for the advancement of cardiology

Statins may reduce death from, severity of COVID-19 among those with heart disease or high blood pressure Research published today in The Public Library of Science ONE, PLOS ONE, examined the relationship between use of medications to control cholesterol or blood pressure levels, and the risk of death among people who were hospitalized due to COVID-19.

Death disruptor: how an Australian funnel-web spider may help human hearts A protein in the venom of a deadly Australian funnel-web spider may be able to reduce cardiac damage from heart attacks and extend the life of donor hearts used in transplants, according to new research.

Comorbidities and COVID: A much higher risk of death While some countries are vaccinating their way out of the COVID-19 pandemic and are starting to see an easing of restrictions, other countries in South Asia are experiencing a new wave of infections that are causing devastation to their populations and healthcare systems.

Fruit and Vegetable Intake and Mortality Results From 2 Prospective Cohort Studies of US Men and Women and a Meta-Analysis of 26 Cohort Studies

Heart patients three times more likely to have diabetes than general population Nearly 30% of patients with coronary artery disease have diabetes, according to a large study published on World Health Day in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1 That compares to a diabetes prevalence of around 9% in the general population.2 There was wide geographical variation, with 60% of heart disease patients in Gulf countries having diabetes compared to 20% in Europe.

People with severe gum disease may be twice as likely to have increased blood pressure Adults with periodontitis, a severe gum infection, may be significantly more likely to have higher blood pressure compared to individuals who had healthy gums, according to new research published today in Hypertension, an American Heart Association journal.

Instant death from heart attack more common in people who do not exercise Heart disease is the leading cause of death globally and prevention is a major public health priority. The beneficial impact of physical activity in stopping heart disease and sudden death on a population level is well documented. This study focused on the effect of an active versus sedentary lifestyle on the immediate course of a heart attack – an area with little information.

Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study Left atrial appendage closure (LAAC) with AMPLATZER occluders is used for stroke prevention in atrial fibrillation (AF). Net clinical benefit compared to medical therapy has not been tested. The aim of this study was to test whether long-term clinical outcome after LAAC with AMPLATZER occluders may be similar to medical therapy.

Cell Therapy for Anthracycline-Induced Cardiomyopathy Safe, Feasible Fran Lowry In yet another trial of cell therapy for heart failure, this time in cancer survivors with anthracycline-induced cardiomyopathy (AIC), administration of allogeneic bone marrow-derived mesenchymal stromal cells (allo-MSCs) was shown to be safe and feasible.

Randomized Trial of Transfusion Strategies in Patients With Myocardial Infarction and Anemia - REALITY The REALITY trial showed that a restrictive PRBC transfusion strategy (transfusion for Hgb ≤8 g/dl, goal Hgb 8-10 g/dl) is noninferior to a more liberal strategy (transfusion for Hgb ≤10 g/dl, goal Hgb >11 g/dl).

Redefining CVD Risk: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Citing the strong overlap between heart disease, kidney disease, type 2 diabetes, and obesity, the American Heart Association (AHA) has for the first time formally defined what they are calling cardiovascular-kidney-metabolic (CKM) syndrome.

ACP Revises Standard on Cardiorespiratory Death Determination The American College of Physicians (ACP) has issued a new position paper on determination of death that includes a clarification to the 1981 Uniform Determination of Death Act (UDDA), but otherwise reaffirms the current standards.

World Heart Day On World Heart Day, 29 September 2020, we’re asking the world to Use Heart to beat CVD ... for your loved ones, society and you.

European Society of Cardiology (ESC) Congress 2020. CONFERENCE NEWS

Major Indexing Service Calls Out Cardiology Journals for Self-Citation More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal.

Novel Lipid Therapies: 5 Things to Know The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.

COVID-19 and cardiovascular diseases: main aspects Igor S. Yavelov MD, PhD, Professor of cardiology

Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov. Dear Colleagues! On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N Mamedov.

Hypertension Clinical Practice Guidelines (ISH, 2020) International Society of Hypertension (ISH) The International Society of Hypertension (ISH) released their global recommendations on the management of hypertension in adults aged 18 years and older in June 2020.

Social Isolation Tied to Higher Risk of CV Events, Death Social isolation is associated with an increased risk of a cardiovascular event of more than 40%, and of all-cause mortality approaching 50%, new research suggests.